3 ms·
Reading the article, it doesn't seem so. The drug looks promising, even though it will probably not work in all cases.
by pindab0ter 2y ago
Reading the article, it doesn't seem so.
The drug looks promising, even though it will probably not work in all cases.
- kettleballroll 2y agoI disagree. This article is typical embellishment from the university that produced the research. The reality is that they're likely pre-trial stage. Even if they make it through all stages of clinical trials (historically, chances of a drug candidate doing that are 2-5%), that usually takes the better part of a decade. So the answer is "no, we're very far from curing it".
- hagbard_c 2y agoThey're at phase 2a trial stage, study start was at 2024-06-05, completion estimated 2025-12: https://clinicaltrials.gov/study/NCT06393452?term=pp405&rank=1 https://clinicaltrials.gov/study/NCT06393452?term=pp405&rank...